Seeking Fresh Start From Its Troubles, Cassava Changes Its Name To Filana

Seeking Fresh Start From Its Troubles, Cassava Changes Its Name To Filana As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The FDA says Novo failed to report suspected incidents of GLP-1 side effects, as required by law. https://kffhealthnews.org/morning-breakout/embattled-biotech-cassava-sciences-changes-name-to-filana-therapeutics/